Incorporation of T-cell epitopes from tetanus and diphtheria toxoids into in-silico-designed hypoallergenic vaccine may enhance the protective immune response against allergens

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 395

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-23-5_011

تاریخ نمایه سازی: 27 مرداد 1399

Abstract:

Objective(s): New generation of allergy vaccines is capable of promoting the development of protective IgG and blocking the functionality of allergen-specific IgE. We incorporated universal and powerful T-cell epitopes from tetanus and diphtheria toxoids (TD epitope) into recombinant Che a 2, the well-known allergic profilin of Chenopodium album, to determine its immunological properties.Materials and Methods: The sequence and accordingly the structure of the recombinant Che a 2 was altered to generate a hypoallergenic variant (rChe a 2.rs). Moreover, TD epitope was incorporated to produce a novel vaccine that was nominated as rChe a 2.rsT.D. The effect of treatment with these variants was evaluated on the generation of allergen-specific IgG class, as well as lymphocyte proliferation in mice. Moreover, IgE-binding characteristics of the allergic patients’ sera were determined by ELISA and proliferation and cytokine production was measured in T-cells. Results: ELISA and dot blot revealed strong reduction of the IgE-reactivity of human sera to the variants of Che a 2 as compared to the wild-type molecule. Furthermore, Che a 2.rs and Che a 2.rsT.D induced much lower levels of IL5 and IL13 secretion from allergic patients’ PBMCs in comparison to wild-type Che a 2 protein. In mice, rChe a 2.rsT.D induced high titers of Che a 2-specific IgG antibody capable of blocking IgE-binding to rChe a 2 and induced lymphocyte proliferation more potently than rChe a 2.rs. Conclusion: Collectively, incorporation of T-cell epitopes of tetanus and diphtheria into hypoallergenic vaccines can dramatically enhance anti-allergic immune mechanisms, particularly in poor responders.

Authors

Ali Ghasemi

Department of Biochemistry and Hematology, Faculty of Medicine Semnan University of Medical Sciences, Semnan, Iran

Reza Falak

Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

Mohsen Mohamadi

The Persian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran

Soheila June Maleki

US Department of Agriculture, Agricultural Research Service, Southern Regional Research Center, New Orleans, Louisiana, USA

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Arnedo-Pena A, Romeu-Gracia MA, Bellido-Blasco JB, Meseguer-Ferrer N, Silvestre-Silvestre E, ...
  • Pawankar R. Allergic rhinitis and asthma: are they manifestations of ...
  • Assarehzadegan MA, Shakurnia A, Amini A. The most common aeroallergens ...
  • Bischoff SC. Role of mast cells in allergic and non-allergic ...
  • Matsuo H, Yokooji T, Taogoshi T. Common food allergens and ...
  • Pomes A. Relevant B cell epitopes in allergic disease. Int ...
  • Zieglmayer P, Focke-Tejkl M, Schmutz R, Lemell P, Zieglmayer R, ...
  • Niespodziana K, Focke-Tejkl M, Linhart B, Civaj V, Blatt K, ...
  • Linhart B, Valenta R. Vaccines for allergy. Curr Opin Immunol  ...
  • Focke M, Marth K, Flicker S, Valenta R. Heterogeneity of ...
  • Curin M, Reininger R, Swoboda I, Focke M, Valenta R, ...
  • Moghaddam MV, Fallahpour M, Mohammadi M, Varaee FR, Mokhtarian K, ...
  • Valenta R, Kraft D. From allergen structure to new forms ...
  • Assarehzadegan MA, Sankian M, Jabbari F, Tehrani M, Varasteh A. ...
  • Prickett SR, Rolland JM, O’Hehir RE. Immunoregulatory T cell epitope ...
  • Prickett SR, Voskamp AL, Phan T, Dacumos-Hill A, Mannering SI, ...
  • Assarehzadegan M-A, Sankian M, Jabbari F, Tehrani M, Varasteh A. ...
  • Thalhamer T, Dobias H, Stepanoska T, Proll M, Stutz H, ...
  • Mothes-Luksch N, Stumvoll S, Linhart B, Focke M, Krauth M-T, ...
  • Asturias J, Ibarrola I, Arilla M, Vidal C, Ferrer A, ...
  • Fraser CC, Altreuter DH, Ilyinskii P, Pittet L, LaMothe RA, ...
  • Diethelm-Okita BM, Okita DK, Banaszak L, Conti-Fine BM. Universal epitopes ...
  • Vallier P, Dechamp C, Valenta R, Vial O, Deviller P. ...
  • Valenta R, Duchene M, Ebner C, Valent P, Sillaber C, ...
  • Cuesta-Herranz J, Lazaro M, Figueredo E, Igea JM, Umpierrez A, ...
  • Westritschnig K, Linhart B, Focke-Tejkl M, Pavkov T, Keller W, ...
  • Ganglberger E, Radauer C, Wagner S, Ríordáin GÓ, Beezhold DH, ...
  • Fedorov AA, Ball T, Mahoney NM, Valenta R, Almo SC. ...
  • Thorn KS, Christensen HE, Shigeta Jr R, Huddler Jr D, ...
  • Amini A, sankian M, Assarehzadegan MA, Vahedi F, Varasteh A. ...
  • Aoki W, Ueda M. Characterization of antimicrobial peptides toward the ...
  • Mohammadi M, Mokhtarian K, Kardar GA, Farrokhi S, Sadroddiny E, ...
  • Mohammadi M, Falak R, Mokhtarian K, Khoramizadeh MR, Sadroddiny E, ...
  • Ahlborg N, Ling IT, Holder AA, Riley EM. Linkage of ...
  • Laubreton D, Bay S, Sedlik C, Artaud C, Ganneau C, ...
  • Westritschnig K, Focke M, Verdino P, Goessler W, Keller W, ...
  • Sallusto F, Lanzavecchia A, Araki K, Ahmed R. From vaccines ...
  • Diethelm-Okita BM, Okita DK, Banaszak L, Conti-Fine BM. Universal epitopes ...
  • Milgrom H, Huang H. Allergic disorders at a venerable age: ...
  • Bateman ED, Hurd S, Barnes P, Bousquet J, Drazen J, ...
  • نمایش کامل مراجع